Potential benefits of ticagrelor beyond platelet inhibition

Cardiology. 2013;125(1):31-3. doi: 10.1159/000350358. Epub 2013 Apr 20.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Coronary Syndrome / complications*
  • Adenosine / analogs & derivatives*
  • Female
  • Humans
  • Male
  • Peripheral Arterial Disease / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Purinergic P2Y Receptor Antagonists / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Adenosine